Turk Ilac ve Serum Sanayi AS Market Cap ($17.88 Million)
Market Cap & Net Worth: Turk Ilac ve Serum Sanayi AS (TRILC)
Turk Ilac ve Serum Sanayi AS market cap. Turk Ilac ve Serum Sanayi AS (IS:TRILC) has a market capitalization of $17.88 Million (TL798.49 Million) as of November 8, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #25281 globally and #406 in its home market, demonstrating a 8.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Turk Ilac ve Serum Sanayi AS's stock price TL0.77 by its total outstanding shares 1037000000 (1.04 Billion). Also see cash efficiency ratio of Turk Ilac ve Serum Sanayi AS for how efficiently the company converts equity into cash flow.
Turk Ilac ve Serum Sanayi AS Market Cap History (2021–2026)
Turk Ilac ve Serum Sanayi AS market cap history from 2021 to 2026. Data shows change from $271.75 Million to $17.88 Million (-28.66% CAGR). Check Turk Ilac ve Serum Sanayi AS (TRILC) share price today for real-time trading data and today's change.
Turk Ilac ve Serum Sanayi AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Turk Ilac ve Serum Sanayi AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Turk Ilac ve Serum Sanayi AS equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.15x
Turk Ilac ve Serum Sanayi AS's market cap is 0.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.38x
Turk Ilac ve Serum Sanayi AS's market cap is 5.38 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $271.75 Million | $672.60 Million | $37.14 Million | 0.40x | 7.32x |
| 2022 | $313.09 Million | $833.44 Million | $66.38 Million | 0.38x | 4.72x |
| 2023 | $265.47 Million | $2.77 Billion | $152.63 Million | 0.10x | 1.74x |
| 2024 | $389.04 Million | $2.57 Billion | $72.36 Million | 0.15x | 5.38x |
Competitor Companies of TRILC by Market Capitalization
Companies near Turk Ilac ve Serum Sanayi AS in the global market cap rankings as of November 8, 2026. Also see how large is Turk Ilac ve Serum Sanayi AS's balance sheet for a full breakdown of the balance sheet.
Key companies related to Turk Ilac ve Serum Sanayi AS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Turk Ilac ve Serum Sanayi AS (2021–2026)
Market capitalization of Turk Ilac ve Serum Sanayi AS from 2021 to today. Between 2021 and today, Turk Ilac ve Serum Sanayi AS's market cap moved from $271.75 Million to $ 17.88 Million, with a yearly change of -28.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL17.88 Million | -95.21% |
| 2025 | TL373.48 Million | -4.00% |
| 2024 | TL389.04 Million | +46.54% |
| 2023 | TL265.47 Million | -15.21% |
| 2022 | TL313.09 Million | +15.21% |
| 2021 | TL271.75 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Turk Ilac ve Serum Sanayi AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.88 Million USD |
| MoneyControl | $17.88 Million USD |
| MarketWatch | $17.88 Million USD |
| marketcap.company | $17.88 Million USD |
| Reuters | $17.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Turk Ilac ve Serum Sanayi AS
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. Turk Ilac Ve Serum Sanayi Anonim Sirketi was founded in 2010 and is headquartered in Anka… Read more